扶正祛风汤治疗气虚型慢性荨麻疹的效果及对C反应蛋白、血清淀粉样蛋白A、D-二聚体水平的影响

doi:10.20047/j.issn1673-7210.2023.26.35

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (625 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Fuzheng Qufeng Decoction on the treatment of chronic urticaria (CU) with qi deficiency type and its influence on C-reactive protein (CRP), serum amyloid A (SAA), and D-dimer (D-D) levels. Methods A total of 98 CU patients with qi deficiency type admitted to Guilin Municipal Hospital of Traditional Chinese Medicine from January 2020 to January 2022 were selected and divided into two groups according to the random number table method, with 49 cases in each group. The control group received Loratadine Tablets and Vitamin C Tablets, and the observation group received Fuzheng Qufeng Decoction, all treated continuously for 14 d. The clinical efficacy, traditional Chinese medicine syndrome scores, 7-day Urticaria Activity Decoction (UAS7), chronic urticaria quality of life questionnaire (GU-Q2oL), and levels of CRP, SAA, and D-D were compared between two groups before and after treatment. Results The clinical efficacy of the observation group was better than that of the control group (P＜0.05). After treatment, the traditional Chinese medicine syndrome scores, UAS7, and GU-Q2oL scores of the two groups were lower than before treatment, and the observation group was lower than the control group, the differences were statistically significant (P＜0.05). After treatment, the plasma levels of CRP, SAA and D-D in both groups were lower than before treatment, and the observation group was lower than the control group the differences were statistically significant(P＜0.05). Conclusion Fuzheng Qufeng Decoction has a definite therapeutic effect on CU of qi deficiency type, and can effectively improve skin lesions and itching symptoms. Its mechanism may be related to regulating inflammation and coagulation factor levels.

Key words： Chronic urticaria Qi deficiency type Fuzheng Qufeng Decoction C-reactive protein Serum amyloid A D-dimer

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MA Anzhe1 MO Wei2 CHEN Jingjing3

Cite this article:

MA Anzhe1 MO Wei2 CHEN Jingjing3. Effect of Fuzheng Qufeng Decoction on treating chronic urticaria of Qi deficiency type and its influence on C-reactive protein, serum amyloid A, and D-dimer levels#br#[J]. 中国医药导报, 2023, 20(26): 161-164.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.26.35 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I26/161

[1] 中华医学会皮肤性病学分会荨麻疹研究中心.中国荨麻疹诊疗指南（2018版）[J].中华皮肤科杂志，2019，52（1）：1-5.
[2] 赵作涛.慢性荨麻疹诊治：现状与展望[J].中华皮肤科杂志，2021，54（12）：1105-1109.
[3] 朱红梅，任捷，韩凌，等.母乳乳清蛋白联合抗组胺药治疗慢性特发性荨麻疹的疗效和安全性观察[J].中国中西医结合皮肤性病学杂志，2022，21（2）：129-131.
[4] 中华医学会皮肤性病学分会荨麻疹研究中心.抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识[J].中华皮肤科杂志，2021，54（12）：1057-1062.
[5] 张雪珥，庞尧斌，王栩芮，等.艾儒棣运用“伏瘀”理论治疗慢性荨麻疹复发经验[J].中医杂志，2022，63（12）：1113- 1117.
[6] 刘茜茜，王位.消风止痒汤联合睡眠疗法治疗慢性荨麻疹临床研究[J].新中医，2022，54（2）：131-134.
[7] 宋印娥，冯倩.免疫炎性相关指标及血浆D二聚体水平变化在慢性荨麻疹患者的检测价值[J].血栓与止血学，2022，28（3）：908-910.
[8] 吴桂菊，赵莹，侯强.D二聚体及炎性因子检测在慢性荨麻疹患者中的诊断价值[J].血栓与止血学，2021，27（2）：206-208.
[9] 中华中医药学会皮肤科分会.瘾疹（荨麻疹）中医治疗专家共识[J].中国中西医结合皮肤性病学杂志，2017，16（3）：274-275.
[10] 中华人民共和国国家标准（ZY/T001.8-1994）：中医皮肤科病证诊断疗效标准[S].国家中医药管理局，1944.
[11] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：292-295.
[12] Zuberbier T，Aberer W，Asero R，et al. The EAACI/ GA2LEN/EDF/WAO guideline for the definition，classification，diagnosis and management of urticaria [J]. Allergy，2018，73（7）：1393-1414.
[13] 于淼，陈玉迪，刘擘，等.中文版慢性荨麻疹生活质量问卷（CU-Q2oL）信效度验证[J].中华皮肤科杂志，2020，53（12）：992-997.
[14] Cho YT，Chan TC，Lee CH，et al. Taiwanese dermatological association consensus for the definition，classification，diagnosis，and management of urticaria：A 2021 update [J]. J Formos Med Assoc，2022，121（7）：1191-1203.
[15] 宋晓婷，于淼，刘擘，等.慢性自发性荨麻疹的治疗[J].中华临床免疫和变态反应杂志，2021，15（6）：677-683.
[16] 中华医学会皮肤性病学分会荨麻疹研究中心.中国荨麻疹诊疗指南（2022版）[J].中华皮肤科杂志，2022，55（12）：1041-1049.
[17] 杨霄，闫小宁，蔺莉，等.基于数据挖掘探析韩世荣教授治疗慢性荨麻疹的用药规律[J].湖南中医药大学学报，2022，42（4）：665-670.
[18] 岳颖，侯淑萍.中医药治疗慢性荨麻疹药理作用和临床应用的研究进展[J].中草药，2022，53（23）：7596-7605.
[19] 高然，李乃芳，崔铖，等.王莒生教授巧用白芍-赤芍配伍治疗皮肤科疾病的经验浅析[J].中国医药科学，2023，13（3）：95-98.
[20] Yanase Y，Takahagi S，Ozawa K，et al. The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria [J]. Cells，2021，10（7）：1759.
[21] 中国妇幼保健协会临床诊断与实验医学分会.SAA单独和与CRP联合检测在儿童感染性疾病中的应用专家共识[J].检验医学，2021，36（7）：685-690.
[22] 杨丽君，王思，刘春景，等.慢性荨麻疹患儿血清25- OH-VD、FⅦa、FⅫa及D-D表达及意义[J].国际检验医学杂志，2018，39（23）：2901-2903，2907.
[23] 白宏，别蓓蓓，常翠翠，等.黄芪甲苷的药理活性研究进展[J].西北药学杂志，2022，37（3）：198-202.
[24] 吴明权，彭伟，周许，等.生地黄活血化瘀功效本草考证及临床应用进展[J].中华中医药杂志，2020，35（7）：3553-3556.
[25] 李洁，邵蒙苏，王盈蕴，等.蝉蜕的临床应用及其用量探究[J].长春中医药大学学报，2021，37（3）：508-511.
[26] 高丽娜，周利润，李曼曼，等.硫酸化修饰对玄参多糖抗炎活性的影响[J].中国现代应用药学，2021，38（12）：1431-1435.